The AMPP study was undertaken in 2004 and involved posting questionnaires to 120,000 households in the USA.[Silberstein et al., 2007; AMF website] The questionnaire included questions about headache frequency, severity, medication use, and impact on daily functioning.[Silberstein et al., 2007; AMF website] During the second phase of the study, 24,000 of the respondents who reported ‘severe’ headache were contacted for a more detailed follow-up survey.[AMF website]

The results of the AMPP study showed that migraine is a frequent and under-recognised condition in the USA.[Silberstein et al., 2007] At the time the study was conducted, there were many barriers to treatment, and many patients with migraine did not receive what they perceived to be adequate treatment.[Silberstein et al., 2007] The AMPP study estimated a crude prevalence of chronic migraine of 0.25–1.92%, depending on age group, with a prevalence of 0.91% in the total sample.[Buse et al., 2012] Prevalence was highest among females, and appeared to decrease with increasing household income.[Buse et al., 2012] Among females with migraine, 7.45% had chronic migraine, and among males with migraine, 8.47% had chronic migraine.[Buse et al., 2012]

References:
American Migraine Foundation website. https://americanmigrainefoundation.org/resource-library/ampp/. Accessed February 2022.

Buse DC, Manack AN, Fanning KM, et al. Chronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention study. Headache 2012; 52 (10): 1456–1470.

Silberstein S, Loder E, Diamond S, et al. Probable migraine in the United States: results of the American Migraine Prevalence and Prevention (AMPP) study. Cephalalgia 2007; 27 (3): 220–229.

Other references used on slide:
Diamond S, Bigal ME, Silberstein S, et al. Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention study. Headache 2007; 47 (3): 355–363. Lipton RB, Bigal ME, Diamond M, et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 2007; 68 (5): 343–349.